NYSE Euronext believes that any kind of merger with Nasdaq OMX — whether the Big Board were the buyer or the seller — makes little strategic sense, and antitrust regulators would block it, according to a source close to the company.
Inside these posts: Antitrust penalty
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Abbott must pay $3.5M in Glaxo HIV drug case
From Bloomberg News | A federal jury has ordered Abbott Laboratories to pay drug giant GlaxoSmithKline $3.5 million in damages in an antitrust lawsuit claiming Abbott sought to stifle competition over HIV drugs when it quadrupled the price of its AIDS medicine Norvir in 2003.
Toys R Us to pay $1.3M antitrust penalty
Privately-held Toys R Us has agreed to pay a $1.3 million penalty for violating a 1998 order that barred it from pushing suppliers to refuse to sell to competitors or from urging limits to those sales, the Federal Trade Commission said Tuesday.
The FTC said in a complaint that Toys R Us subsidiary Babies R Us had asked suppliers what they were charging discounters and complained to them about discounts that other retailers were giving consumers, the FTC said. Get the full story »